John B Buse

John B Buse

UNVERIFIED PROFILE

Are you John B Buse?   Register this Author

Register author
John B Buse

John B Buse

Publications by authors named "John B Buse"

Are you John B Buse?   Register this Author

100Publications

1099Reads

31Profile Views

Real-world evidence: the devil is in the detail.

Diabetologia 2020 Sep 15;63(9):1694-1705. Epub 2020 Jul 15.

Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-020-05217-1DOI Listing
September 2020

Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters.

Diabetes Care 2020 08 16;43(8):1695-1703. Epub 2020 Jun 16.

Diabetes Research Centre, University of Leicester, Leicester, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc20-1192DOI Listing
August 2020

Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients Treated with Gemcitabine for Stage IV Pancreatic Cancer.

Oncologist 2020 Jul 17;25(7):579-584. Epub 2020 Mar 17.

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356778PMC
July 2020

COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports.

Diabetes Care 2020 07 14;43(7):1378-1381. Epub 2020 May 14.

Division of Metabolism, Endocrinology and Nutrition, VA Puget Sound Health Care System and University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci20-0024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305002PMC
July 2020

Decreased Antihyperglycemic Drug Use Driven by High Out-of-Pocket Costs Despite Medicare Coverage Gap Closure.

Diabetes Care 2020 Jul 8. Epub 2020 Jul 8.

Department of Epidemiology, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc19-1880DOI Listing
July 2020

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.

Diabetes Care 2020 Jul 9. Epub 2020 Jul 9.

Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc20-0437DOI Listing
July 2020

Inpatient Transition to Virtual Care During COVID-19 Pandemic.

Diabetes Technol Ther 2020 06 12;22(6):444-448. Epub 2020 May 12.

Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/dia.2020.0206DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262638PMC
June 2020

Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs.

Nat Biomed Eng 2020 05 3;4(5):499-506. Epub 2020 Feb 3.

Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41551-019-0508-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231631PMC
May 2020

Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation.

Adv Mater 2020 Apr 18;32(13):e1902004. Epub 2019 Aug 18.

Department of Bioengineering, University of California, Los Angeles, CA, 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/adma.201902004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141789PMC
April 2020

Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes.

Circulation 2020 Apr 26;141(17):1360-1370. Epub 2020 Feb 26.

Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, UK (M.A.B., R.A.P., R.R.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.043353DOI Listing
April 2020

Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier's gangrene.

BMJ Open Diabetes Res Care 2020 01;8(1)

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjdrc-2019-000985DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039596PMC
January 2020

Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: Results From the EXSCEL Trial.

Circ Cardiovasc Interv 2019 12 22;12(12):e008018. Epub 2019 Nov 22.

Duke Clinical Research Institute (P.M., N.J.P., A.F.H., R.J.M., M.R.P. W.S.J.), Duke University School of Medicine, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.119.008018DOI Listing
December 2019

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults.

Diabetes Care 2019 11 30;42(11):2065-2074. Epub 2019 Aug 30.

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc19-0162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804610PMC
November 2019

Insights Into Patients' Experience With Type 1 Diabetes: Exit Interviews From Phase III Studies of Sotagliflozin.

Clin Ther 2019 11 3;41(11):2219-2230.e6. Epub 2019 Oct 3.

Lexicon Pharmaceuticals Inc, The Woodlands, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2019.09.003DOI Listing
November 2019

Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example.

Diabetes Obes Metab 2019 10 30;21(10):2203-2210. Epub 2019 Jun 30.

Department of Health Sciences, Diabetes Research Centre, University of Leicester, Leicester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13804DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771751PMC
October 2019

Characteristics and Delivery of Diabetes Shared Medical Appointments in North Carolina.

N C Med J 2019 Sep-Oct;80(5):261-268

MD/PhD candidate, Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18043/ncm.80.5.261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152508PMC
October 2019

Reasons for Increases in Complications of Diabetes.

Authors:
John B Buse

JAMA 2019 10;322(15):1518-1519

School of Medicine, University of North Carolina, Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2019.13036DOI Listing
October 2019

Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting.

Diabetes Care 2019 06;42(6):e89-e91

Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc18-1609DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118246PMC
June 2019

Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers.

Diabetes Obes Metab 2019 05 4;21(5):1223-1236. Epub 2019 Mar 4.

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13647DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459697PMC
May 2019

Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia.

Proc Natl Acad Sci U S A 2019 05 16;116(22):10744-10748. Epub 2019 May 16.

Department of Bioengineering, University of California, Los Angeles, CA 90095;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1901967116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561193PMC
May 2019

Impact of metformin use on the cardiovascular effects of dipeptidyl peptidase-4 inhibitors: An analysis of Medicare claims data from 2007 to 2015.

Diabetes Obes Metab 2019 04 18;21(4):854-865. Epub 2018 Dec 18.

Department of Medicine, Division of Endocrinology and Metabolism, University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13589DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527500PMC
April 2019

Evidence supports prediabetes treatment.

Science 2019 04;364(6438):341-342

Division of Endocrinology and Diabetes, University of Virginia, Charlottesville, VA 22903, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aax3548DOI Listing
April 2019

Health-related quality of life in people with type 2 diabetes participating in the LEADER trial.

Diabetes Obes Metab 2019 03 25;21(3):525-532. Epub 2018 Oct 25.

Nuffield Department of Population Health, Health Economics Research Centre, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587748PMC
March 2019

Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System.

Diabetes Care 2019 02 7;42(2):e21-e23. Epub 2018 Dec 7.

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc18-1893DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341287PMC
February 2019

Identifying individual risk rare variants using protein structure guided local tests (POINT).

PLoS Comput Biol 2019 02 19;15(2):e1006722. Epub 2019 Feb 19.

Department of Statistics, North Carolina State University, Raleigh, North Carolina, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pcbi.1006722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396946PMC
February 2019

Advances in transdermal insulin delivery.

Adv Drug Deliv Rev 2019 01 8;139:51-70. Epub 2018 Dec 8.

Department of Bioengineering, University of California, Los Angeles, CA 90095, USA; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695, USA; California NanoSystems Institute, Jonsson Comprehensive Cancer Center, Center for Minimally Invasive Therapeutics, University of California, Los Angeles, CA 90095, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addr.2018.12.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556146PMC
January 2019

Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator.

Sci Transl Med 2019 01;11(475)

vTv Therapeutics Inc. and vTv Therapeutics LLC, High Point, NC 27265, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aau3441DOI Listing
January 2019

Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial.

Diabetes Obes Metab 2018 12 10;20(12):2885-2893. Epub 2018 Oct 10.

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13545DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231963PMC
December 2018

Liraglutide and Glycaemic Outcomes in the LEADER Trial.

Diabetes Ther 2018 Dec 3;9(6):2383-2392. Epub 2018 Nov 3.

University of North Carolina School of Medicine, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s13300-018-0524-z
Publisher Site
http://dx.doi.org/10.1007/s13300-018-0524-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250637PMC
December 2018

Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults.

Diabetes Care 2018 09 16;41(9):1998-2009. Epub 2018 Jul 16.

Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc17-2285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105327PMC
September 2018

Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol.

Diabetes Technol Ther 2018 09 21;20(9):571-575. Epub 2018 Aug 21.

5 Children's and Youth Hospital Auf der Bult , Hannover Medical School, Hannover, Germany .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/dia.2018.0246DOI Listing
September 2018

Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience.

Diabetes Care 2018 08 14;41(8):1783-1791. Epub 2018 Jun 14.

University of North Carolina School of Medicine, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc17-2677DOI Listing
August 2018

Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?

Diabetes Care 2018 08 25;41(8):1560-1562. Epub 2018 Jun 25.

Division of Endocrinology, Diabetes & Clinical Nutrition, Oregon Health & Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci18-0025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054497PMC
August 2018

Calendar time as an instrumental variable in assessing the risk of heart failure with antihyperglycemic drugs.

Pharmacoepidemiol Drug Saf 2018 08 26;27(8):857-866. Epub 2018 Jun 26.

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapell Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.4578DOI Listing
August 2018

Primum Non Nocere: Refocusing Our Attention on Severe Hypoglycemia Prevention.

Diabetes Care 2018 08;41(8):1557-1559

Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC

View Article

Download full-text PDF

Source
http://care.diabetesjournals.org/lookup/doi/10.2337/dci18-00
Publisher Site
http://dx.doi.org/10.2337/dci18-0020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054498PMC
August 2018

Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet: A Word of Caution.

Pediatrics 2018 08;142(2)

Chief, Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina at Chapel Hill.

View Article

Download full-text PDF

Source
http://pediatrics.aappublications.org/lookup/doi/10.1542/ped
Publisher Site
http://dx.doi.org/10.1542/peds.2018-1536BDOI Listing
August 2018